Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the context of its monetization process
03 mai 2024 11h30 HE
|
Mithra Pharmaceuticals
Liege, Belgium, 3 May 2024 – 17:30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces that, after diligent evaluation of several binding offers, Mithra...
Mithra updates on offers received in the context of its monetization process and on its Annual Report 2023
29 avr. 2024 01h00 HE
|
Mithra Pharmaceuticals
Mithra has received binding offers for selected assets, including Estetra SRL, as part of its monetization process.
Mithra secures court protection measures to advance monetization process
22 avr. 2024 01h00 HE
|
Mithra Pharmaceuticals
Court Grants "Transfer under Judicial Supervision" for CDMO facility, safeguarding Mithra's activities and expediting the M&A process for its Contract Development and Manufacturing...
Mithra reports full year 2023 financial results
08 mars 2024 01h00 HE
|
Mithra Pharmaceuticals
Mithra reports full year 2023 financial results Revenues were EUR 40.2 million, down from the 2022 result of EUR 67.0 million which was positively impacted by exceptional upfront cash payments from...
Mithra announces changes to its executive management
05 mars 2024 01h01 HE
|
Mithra Pharmaceuticals
Mithra announces changes to its executive management Liege, Belgium, 05 March 2024 – 07:00 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to women’s health, today announces the...
Mithra initiates monetization process, receives bridge loan from existing lenders
05 mars 2024 01h00 HE
|
Mithra Pharmaceuticals
Mithra initiates monetization process, receives bridge loan from existing lenders Mithra appoints advisors and initiates a process to monetize its assets or execute a sale of its businessMithra...
DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase
29 févr. 2024 05h42 HE
|
Mithra Pharmaceuticals
DONESTA® safety study for menopause completes treatment phase and advances to data management & reporting phase Mithra on-track for completion of Phase 3 study for DONESTA® to treat...
Mithra sells shares in Mayne Pharma
15 févr. 2024 12h23 HE
|
Mithra Pharmaceuticals
Mithra sells shares in Mayne Pharma Mithra sold all 4,221,815 shares it held in Mayne Pharma for EUR ~12.8 millionAs the Mayne Pharma shares were pledged to the secured lenders of Mithra,...
Mithra updates on cash position
06 févr. 2024 01h00 HE
|
Mithra Pharmaceuticals
Mithra updates on cash position Mithra's current cash of EUR 6.5 million is expected to cover its current cash runway through early MarchMithra is actively engaging with...
Mithra updates on cash position
06 févr. 2024 01h00 HE
|
Mithra Pharmaceuticals
Mithra updates on cash position Mithra's current cash of EUR 6.5 million is expected to cover its current cash runway through early MarchMithra is actively engaging with...